Cargando…
Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis?
Mycobacterium abscessus is a nontuberculous mycobacterium (NTM) of particular concern in individuals with obstructive lung diseases such as cystic fibrosis (CF). Treatment requires multiple drugs and is characterised by high rates of relapse; thus, new strategies to limit infection are urgently requ...
Autores principales: | Warner, Sherridan, Blaxland, Anneliese, Counoupas, Claudio, Verstraete, Janine, Zampoli, Marco, Marais, Ben J., Fitzgerald, Dominic A., Robinson, Paul D., Triccas, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459431/ https://www.ncbi.nlm.nih.gov/pubmed/37631881 http://dx.doi.org/10.3390/vaccines11081313 |
Ejemplares similares
-
Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis
por: Hughes, Dominic A., et al.
Publicado: (2021) -
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016) -
Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions
por: Verma, Deepshikha, et al.
Publicado: (2020) -
Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome
por: Zampoli, Marco, et al.
Publicado: (2021) -
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)